NM

New Medical Technologies

Europe, Basel-Stadt, Switzerland, Basel

Description

New Medical Technologies Management provides investment opportunities for all sectors of the emerging medical technology industries.

Investor Profile

New Medical Technologies has backed more than 12 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 17% of its total and boasts 6 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series D rounds (top funding stages).
  • Majority of deals are located in Switzerland, United States, Germany.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (50%)
  • Series A (25%)
  • Series D (8%)
  • Seed (8%)
  • Series Unknown (8%)

Country Focus

  • Switzerland (58%)
  • United States (25%)
  • Germany (8%)
  • Canada (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Biopharma
  • Manufacturing
  • Medical Device
  • Therapeutics
  • Oncology
  • Hospital
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does New Medical Technologies frequently co-invest with?

China Development Industrial Bank (CDIB)
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Credit Suisse
North America, North Carolina, United States, Morrisville
Co-Investments: 1
3i Group
Europe, England, United Kingdom, London
Co-Investments: 2
Mayfield Fund
North America, California, United States, Menlo Park
Co-Investments: 2
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 1
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 3
Alta Berkeley Venture Partners
Europe, England, United Kingdom, London
Co-Investments: 2
CB
North America, Wisconsin, United States, Madison
Co-Investments: 1
Aventic Partners
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2

What are some of recent deals done by New Medical Technologies?

Thommen Medical

Grenchen, Solothurn, Switzerland

Thommen Medical is developer & manufacturer of dental implantology products, Thommen Implant System.

Health CareManufacturingMedicalMedical Device
Series BMay 3, 2002
Thommen Medical

Grenchen, Solothurn, Switzerland

Thommen Medical is developer & manufacturer of dental implantology products, Thommen Implant System.

Health CareManufacturingMedicalMedical Device
Series ADec 14, 2001
Amount Raised: $3,677,507
PTC Therapeutics

South Plainfield, New Jersey, United States

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.

BiotechnologyHealth CareTherapeutics
Series DSep 19, 2001
Amount Raised: $40,000,000
Spexis

Allschwil, Basel-Landschaft, Switzerland

Spexis is a swiss pharma company focusing on the discovery and development of macrocycle drugs addressing high unmet medical needs.

BiotechnologyMedicalPharmaceutical
Series UnknownMay 2, 2001
Amount Raised: $9,250,004
Arpida AG

Reinach, Aargau, Switzerland

Arpida AG is a biopharmaceutical company that focused on the discovery and development of novel products.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BOct 23, 2000
Amount Raised: $22,271,913
Ingenium Pharmaceuticals AG

Planegg, Bayern, Germany

Ingenium Pharmaceuticals AG is discovers and develops molecules for the treatment of neuronal and autoimmune diseases.

Biotechnology
Series BOct 1, 2000
Amount Raised: $43,977,269
Cytos

Schlieren, Zurich, Switzerland

Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies .

BiotechnologyHospitalPharmaceutical
Series BJul 26, 2000
Amount Raised: $32,000,000
Viron Therapeutics

London, Ontario, Canada

Viron Therapeutics is a Biotechnology company

Biotechnology
Series AJan 19, 2000
Amount Raised: $7,317,000
Sunesis Pharmaceuticals

South San Francisco, California, United States

Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.

BiotechnologyHealth CareOncologyPharmaceutical
Series BDec 6, 1999
Amount Raised: $25,200,000
Cytokinetics

South San Francisco, California, United States

Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.

BiopharmaBiotechnologyHealth Care
Series BOct 12, 1999
Amount Raised: $20,000,000

Find More Investors Like New Medical Technologies

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

New Medical Technologies | Pipeseed